P542 Long-term outcomes after switching from originator infliximab to biosimilar in paediatric-onset inflammatory bowel disease patients: a single centre prospective observational study
2017 ◽
Vol 11
(suppl_1)
◽
pp. S355-S356
2016 ◽
Vol 10
(suppl 1)
◽
pp. S384.1-S384
Keyword(s):
2021 ◽
2010 ◽
Vol 138
(5)
◽
pp. S-691-S-692
◽
Keyword(s):
2018 ◽
Vol 50
(3)
◽
pp. 240-246
◽
Keyword(s):